COVID-19 Practical Considerations: How Can We Help Patients With Myeloid Malignancies?
By
Dana-Farber Cancer Institute
FEATURING
David P. Steensma
By
Dana-Farber Cancer Institute
FEATURING
David P. Steensma
Login to view comments.
Click here to Login